Bone Biologics Ownership 2024 | Who Owns Bone Biologics Now?


OverviewFinancialsChart

Institutional Ownership

0.07%

Insider Ownership

6.51%

Retail Ownership

93.42%

Institutional Holders

1.00

Bone Biologics Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SABBY MANAGEMENT, LLC0.07%0.01%10,817-1,489,183-99.28%15,468,000Jun 30, 2023
WELLS FARGO & COMPANY/MN----52-100.00%-Jun 30, 2023
MILLENNIUM MANAGEMENT LLC----17,824-100.00%-Jun 30, 2023
TOWER RESEARCH CAPITAL LLC (TRC)----8,311-100.00%-Jun 30, 2023
WARBERG ASSET MANAGEMENT LLC----30,000-100.00%-Jun 30, 2023
UBS GROUP AG----43,653-100.00%-Jun 30, 2023
MFA WEALTH ADVISORS, LLC----96,774-100.00%-Jun 30, 2023
WALLEYE CAPITAL LLC----806,159-100.00%-Jun 30, 2023

Bone Biologics's largest institutional shareholder is SABBY MANAGEMENT, LLC, holding 0.07% of the company's total share outstanding, currently valued at $15.47M. The top 10 institutional shareholders own together 0.07% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SABBY MANAGEMENT, LLC0.07%0.01%10,817-1,489,183-99.28%15,468,000Jun 30, 2023
WELLS FARGO & COMPANY/MN----52-100.00%-Jun 30, 2023
MILLENNIUM MANAGEMENT LLC----17,824-100.00%-Jun 30, 2023
TOWER RESEARCH CAPITAL LLC (TRC)----8,311-100.00%-Jun 30, 2023
WARBERG ASSET MANAGEMENT LLC----30,000-100.00%-Jun 30, 2023
UBS GROUP AG----43,653-100.00%-Jun 30, 2023
MFA WEALTH ADVISORS, LLC----96,774-100.00%-Jun 30, 2023
WALLEYE CAPITAL LLC----806,159-100.00%-Jun 30, 2023

The largest Bone Biologics shareholder by % of total assets is SABBY MANAGEMENT, LLC. The company owns 10.82K shares of Bone Biologics (BBLG), representing 0.01% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
WELLS FARGO & COMPANY/MN----52-100.00%-Jun 30, 2023
TOWER RESEARCH CAPITAL LLC (TRC)----8,311-100.00%-Jun 30, 2023
MILLENNIUM MANAGEMENT LLC----17,824-100.00%-Jun 30, 2023
WARBERG ASSET MANAGEMENT LLC----30,000-100.00%-Jun 30, 2023
UBS GROUP AG----43,653-100.00%-Jun 30, 2023
MFA WEALTH ADVISORS, LLC----96,774-100.00%-Jun 30, 2023
WALLEYE CAPITAL LLC----806,159-100.00%-Jun 30, 2023
SABBY MANAGEMENT, LLC0.07%0.01%10,817-1,489,183-99.28%15,468,000Jun 30, 2023

As of Jun 30 2023, Bone Biologics's largest institutional buyer is WELLS FARGO & COMPANY/MN. The company purchased -52.00 stocks of BBLG, valued at -.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SABBY MANAGEMENT, LLC0.07%0.01%10,817-1,489,183-99.28%15,468,000Jun 30, 2023
WALLEYE CAPITAL LLC----806,159-100.00%-Jun 30, 2023
MFA WEALTH ADVISORS, LLC----96,774-100.00%-Jun 30, 2023
UBS GROUP AG----43,653-100.00%-Jun 30, 2023
WARBERG ASSET MANAGEMENT LLC----30,000-100.00%-Jun 30, 2023
MILLENNIUM MANAGEMENT LLC----17,824-100.00%-Jun 30, 2023
TOWER RESEARCH CAPITAL LLC (TRC)----8,311-100.00%-Jun 30, 2023
WELLS FARGO & COMPANY/MN----52-100.00%-Jun 30, 2023

As of Jun 30 2023, Bone Biologics's biggest institutional seller is SABBY MANAGEMENT, LLC. The company sold -1.49M shares of BBLG, valued at $15.47M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
WALLEYE CAPITAL LLC----806,159-100.00%-Jun 30, 2023
MFA WEALTH ADVISORS, LLC----96,774-100.00%-Jun 30, 2023
UBS GROUP AG----43,653-100.00%-Jun 30, 2023
WARBERG ASSET MANAGEMENT LLC----30,000-100.00%-Jun 30, 2023
MILLENNIUM MANAGEMENT LLC----17,824-100.00%-Jun 30, 2023
TOWER RESEARCH CAPITAL LLC (TRC)----8,311-100.00%-Jun 30, 2023
WELLS FARGO & COMPANY/MN----52-100.00%-Jun 30, 2023

Bone Biologics's largest sold out institutional shareholder by shares sold is WALLEYE CAPITAL LLC, sold -0.81M shares, valued at -, as of undefined.

Bone Biologics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
FIDELITY CONCORD STREET TRUST0.00%15,816--Feb 29, 2024
VANGUARD INDEX FUNDS0.00%33,461--Dec 31, 2023
FIDELITY CONCORD STREET TRUST0.00%5,900--Feb 29, 2024

Bone Biologics's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 15.82K shares, compromising 0.00% of its total assets.

Bone Biologics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 231-87.50%
31 Mar, 238-27.27%
31 Dec, 2211450.00%
30 Sep, 222-33.33%
30 Jun, 223-
31 Mar, 223-

As of 30 Jun 23, 1 institutions are holding Bone Biologics's shares, representing a decrease of -87.50% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 2310,817-99.57%
31 Mar, 232,502,77313.19%
31 Dec, 222,211,1795249.02%
30 Sep, 2241,338-12.60%
30 Jun, 2247,299-17.98%
31 Mar, 2257,666-

Bone Biologics (BBLG) has 10.82K shares outstanding as of 30 Jun 23, down -99.57% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 230.07%0.03%
31 Mar, 2315.53%4.14%
31 Dec, 2219.36%12135.23%
30 Sep, 220.40%191.25%
30 Jun, 220.46%147.23%
31 Mar, 220.56%-

As of 30 Jun 23, Bone Biologics is held by 0.07% institutional shareholders, representing a 0.03% growth compared to 31 Mar 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 23--100.00%
31 Mar, 234-63.64%
31 Dec, 22111000.00%
30 Sep, 221-50.00%
30 Jun, 222-33.33%
31 Mar, 223-

- institutional shareholders have increased their position in BBLG stock as of 30 Jun 23 compared to 4 in the previous quarter (a -100.00% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 231-50.00%
31 Mar, 232-
31 Dec, 22--
30 Sep, 22--
30 Jun, 22--
31 Mar, 22--

1 institutional shareholders have reduced their position in BBLG stock as of 30 Jun 23 compared to 2 in the previous quarter (a -50.00% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 231-87.50%10,817-99.57%0.07%0.03%--100.00%1-50.00%
31 Mar, 238-27.27%2,502,77313.19%15.53%4.14%4-63.64%2-
31 Dec, 2211450.00%2,211,1795249.02%19.36%12135.23%111000.00%--
30 Sep, 222-33.33%41,338-12.60%0.40%191.25%1-50.00%--
30 Jun, 223-47,299-17.98%0.46%147.23%2-33.33%--
31 Mar, 223-57,666-0.56%-3---

Bone Biologics Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Sep 14, 2023Walsh Deina Hofficer Chief Financial OfficerP-PurchaseBuy8,000$0.64$5.12K15,000
Sep 12, 2023Frelick Jeffofficer Chief Executive OfficerP-PurchaseBuy9,500$0.69$6.53K17,204
Sep 07, 2023Walsh Deina Hofficer Chief Financial OfficerP-PurchaseBuy6,700$0.71$4.76K7,000
Sep 07, 2023Walsh Deina Hofficer Chief Financial OfficerP-PurchaseBuy300$0.70$210.00300
Sep 05, 2023Frelick Jeffofficer Chief Executive OfficerP-PurchaseBuy7,600$0.66$5.02K7,704

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Sep 14, 2023Walsh Deina Hofficer Chief Financial OfficerP-PurchaseBuy8,000$0.64$5.12K15,000
Sep 12, 2023Frelick Jeffofficer Chief Executive OfficerP-PurchaseBuy9,500$0.69$6.53K17,204
Sep 07, 2023Walsh Deina Hofficer Chief Financial OfficerP-PurchaseBuy6,700$0.71$4.76K7,000
Sep 07, 2023Walsh Deina Hofficer Chief Financial OfficerP-PurchaseBuy300$0.70$210.00300
Sep 05, 2023Frelick Jeffofficer Chief Executive OfficerP-PurchaseBuy7,600$0.66$5.02K7,704

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jan 10, 2024Gagnon Robert E.director-Sell----
Mar 29, 2023Hankey Dondirector, 10 percent owner, officer Chairman of the BoardJ-OtherSell33,811$6.30$213.01K-
Mar 29, 2023Hankey Dondirector, 10 percent owner, officer Chairman of the BoardJ-OtherSell500,137---

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jan 19, 2024Walsh Deina Hofficer Chief Financial OfficerA-AwardBuy12,500$3.61$45.13K12,500
Jan 19, 2024Frelick Jeffofficer Chief Executive OfficerA-AwardBuy25,000$3.61$90.25K25,000
Jan 10, 2024Gagnon Robert E.director-A-AwardBuy8$4.68$37.478,015
Jan 10, 2024Gagnon Robert E.director-A-AwardBuy9$4.68$42.129
Jan 10, 2024Gagnon Robert E.director-Sell----
Sep 20, 2023Lucera Erickdirector-A-AwardBuy85,763$0.64$54.89K85,763
Sep 20, 2023Angle Siddhesh Rajendradirector-A-AwardBuy85,763$0.64$54.89K85,763
Sep 20, 2023Stroever Brucedirector-A-AwardBuy85,763$0.64$54.89K85,763
Sep 14, 2023Walsh Deina Hofficer Chief Financial OfficerP-PurchaseBuy8,000$0.64$5.12K15,000
Sep 12, 2023Frelick Jeffofficer Chief Executive OfficerP-PurchaseBuy9,500$0.69$6.53K17,204
Sep 07, 2023Walsh Deina Hofficer Chief Financial OfficerP-PurchaseBuy6,700$0.71$4.76K7,000
Sep 07, 2023Walsh Deina Hofficer Chief Financial OfficerP-PurchaseBuy300$0.70$210.00300
Sep 05, 2023Frelick Jeffofficer Chief Executive OfficerP-PurchaseBuy7,600$0.66$5.02K7,704
Mar 29, 2023Hankey Dondirector, 10 percent owner, officer Chairman of the BoardJ-OtherBuy280,764$6.30$1.77M280,764
Mar 29, 2023Hankey Dondirector, 10 percent owner, officer Chairman of the BoardJ-OtherBuy99,148$6.30$624.63K99,148
Mar 29, 2023Hankey Dondirector, 10 percent owner, officer Chairman of the BoardJ-OtherBuy37,918$6.30$238.88K37,918
Mar 29, 2023Hankey Dondirector, 10 percent owner, officer Chairman of the BoardJ-OtherBuy19,297$6.30$121.57K19,297
Mar 29, 2023Hankey Dondirector, 10 percent owner, officer Chairman of the BoardJ-OtherBuy5,252$6.30$33.09K5,252
Mar 29, 2023Hankey Dondirector, 10 percent owner, officer Chairman of the BoardJ-OtherSell33,811$6.30$213.01K-
Mar 29, 2023Hankey Dondirector, 10 percent owner, officer Chairman of the BoardJ-OtherSell500,137---

The last insider sell of Bone Biologics's stock was made by Gagnon Robert E. on Jan 10 2024, selling - shares at - per share (valued at -). The last insider buy of BBLG was made by Walsh Deina H on Sep 14 2023, buying 8,000 shares at $0.64 per share (worth $5.12K).

Bone Biologics Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 202462300.00%
Q3 202316--
Q1 2023144350.00%
Q3 20226--
Q1 20225--
Q4 202164150.00%
Q1 20202--
Q3 20194--
Q2 20194--
Q1 20193--
Q4 20182--
Q3 2018---
Q1 20185--
Q4 20171--
Q3 201722100.00%
Q1 20172--
Q3 201621200.00%
Q2 201621200.00%
Q1 20165--
Q4 2015229244.44%

6 total buy trades, and 2 total sell trades (buy/sell ratio of 3.00%) were made by Bone Biologics's insiders, as of Q1 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 2024---
Q3 202310--
Q1 2023---
Q3 2022---
Q1 2022---
Q4 2021---
Q1 20202--
Q3 20194--
Q2 20194--
Q1 20192--
Q4 20182--
Q3 2018---
Q1 2018---
Q4 2017---
Q3 2017---
Q1 2017---
Q3 2016---
Q2 2016---
Q1 20161--
Q4 2015-7-

As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Bone Biologics's stocks.

Bone Biologics Peer Ownership


TickerCompany
TNONTenon Medical, Inc.
BJDXBluejay Diagnostics, Inc.
VVOSVivos Therapeutics, Inc.
HSCSHeart Test Laboratories, Inc.
RPIDRapid Micro Biosystems, Inc.
NAOVNanoVibronix, Inc.
TIVCTivic Health Systems, Inc.
INVOINVO Bioscience, Inc.
SINTSintx Technologies, Inc.
NUWENuwellis, Inc.
TLISTalis Biomedical Corporation
RSLSReShape Lifesciences Inc.
MOTSMotus GI Holdings, Inc.

BBLG Ownership FAQ


Bone Biologics is owned by institutional shareholders (0.07%), insiders (6.51%), and public (93.42%). The largest institutional shareholder of Bone Biologics is SABBY MANAGEMENT, LLC (0.07% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).

Bone Biologics's major institutional shareholders are SABBY MANAGEMENT, LLC, WELLS FARGO & COMPANY/MN, MILLENNIUM MANAGEMENT LLC, TOWER RESEARCH CAPITAL LLC (TRC), and WARBERG ASSET MANAGEMENT LLC. The top five shareholders own together 0.07% of the company's share outstanding.

As of Jun 2023, there are 1 institutional shareholders of Bone Biologics.

SABBY MANAGEMENT, LLC owns 10.82K shares of Bone Biologics, representing 0.07% of the company's total shares outstanding, valued at $15.47M (as of Jun 2023).

As of Jun 2023, WELLS FARGO & COMPANY/MN holds 0 shares of Bone Biologics (BBLG), compromising 0% of the company, valued at $0.

MILLENNIUM MANAGEMENT LLC is the third largest holder of Bone Biologics. The company owns 0 of the company's shares outstanding (worth $0).